Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes.

  1. B Thoma,
  2. T A Bird,
  3. D J Friend,
  4. D P Gearing and
  5. S K Dower
  1. Department of Biochemistry, Immunex Corporation, Seattle, Washington 98101.

    Abstract

    Leukemia inhibitory factor (LIF) and oncostatin M (OSM) both bind to the same receptor with high affinity and thus mediate an overlapping spectrum of biological activities, the signal transduction mechanisms for which are unclear. We show that mitogen-activated protein kinases are involved in both the LIF and OSM signal transduction pathways. However, we found that OSM is a much more potent inducer of both mitogen-activated protein kinase activity and biological response, both of which correlate with the expression of a second OSM receptor that does not bind LIF. In addition, different patterns of tyrosine-phosphorylated proteins were stimulated by OSM and LIF. We therefore suggest that the two receptors for OSM can be coupled to different signal transduction events.

    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement